Have Tevogen Bio Holdings Insiders Been Selling Stock?

We'd be surprised if Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shareholders haven't noticed that the Chief Scientific Officer and Global R&D Lead, Neal Flomenberg, recently sold US$250k worth of stock at US$1.17 per share. On the bright side, that sale was only 5.0% of their holding, so we doubt it's very meaningful, on its own.

See our latest analysis for Tevogen Bio Holdings

Tevogen Bio Holdings Insider Transactions Over The Last Year

Notably, that recent sale by Chief Scientific Officer and Global R&D Lead Neal Flomenberg was not the only time they sold Tevogen Bio Holdings shares this year. Earlier in the year, they fetched US$1.62 per share in a -US$1.7m sale. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (US$1.14). So it is hard to draw any strong conclusion from it.

Happily, we note that in the last year insiders paid US$4.5k for 5.61k shares. But insiders sold 1.29m shares worth US$2.0m. Neal Flomenberg sold a total of 1.29m shares over the year at an average price of US$1.55. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

I will like Tevogen Bio Holdings better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Does Tevogen Bio Holdings Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Tevogen Bio Holdings insiders own 92% of the company, currently worth about US$184m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About Tevogen Bio Holdings Insiders?

An insider hasn't bought Tevogen Bio Holdings stock in the last three months, but there was some selling. Despite some insider buying, the longer term picture doesn't make us feel much more positive. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To that end, you should learn about the 6 warning signs we've spotted with Tevogen Bio Holdings (including 3 which don't sit too well with us).

Of course Tevogen Bio Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.